期刊文献+

苯磺酸氨氯地平片治疗社区高血压的临床疗效观察 被引量:1

Clinical curative effect observation of norvasc in the treatment of community hypertension
下载PDF
导出
摘要 目的:观察并分析苯磺酸氨氯地平片在社区高血压临床治疗中的应用价值。方法:2011年6月-2014年6月收治高血压患者100例,按照随机的方式将其分为观察组与对照组,各50例。观察组使用苯磺酸氨氯地平片治疗,对照组则应用缬沙坦氨氯地平片治疗。治疗5周后,对比分析两组治疗有效率和治疗前后的收缩压和舒张压的变化情况。结果:治疗前两组患者的收缩压以及舒张压相比,差异无统计学意义(P>0.05);治疗后观察组的收缩压和舒张压的改善情况及治疗有效率均要显著优于对照组,差异具有统计学意义(P<0.05)。结论:在社区高血压的临床治疗中,苯磺酸氨氯地平片能够显著地缓解患者的临床症状,改善各项指标,有助于促进患者早日康复。 Objective:To observe and analyze the application value of norvasc in the clinical treatment of community hypertension. Methods:100 patients with hypertension were selected from June 2011 to June 2014.They were divided into the observation group and the control group with 50 cases in each according to the random method.The observation group was given norvasc drug treatment,while the control group was given Beibote treatment.After 5 weeks of treatment,the treatment effective rates and the changes of systolic and diastolic blood pressure before and after treatment of two groups were compared and ananlyze.Results:Before treatment,the systolic and diastolic blood pressures of patients in two groups were compared with no significant difference(P>0.05).After treatment,the improved conditions of systolic and diastolic blood pressure and the treatment effective rate of the observation group were significantly better than those of the control group,the difference was statistically significant(P<0.05).Conclusion:In the clinical treatment of community hypertension,norvasc can significantly relieve the clinical symptoms of patients,improve the indicators,and help to promote early rehabilitation of patients.
出处 《中国社区医师》 2015年第14期16-16,18,共2页 Chinese Community Doctors
关键词 苯磺酸氨氯地平片 社区高血压 临床价值 Norvasc Community hypertension Clinical value
  • 相关文献

参考文献4

二级参考文献18

  • 1苟师杨.洛活喜治疗老年收缩期高血压168例观察[J].中国现代医药杂志,2006,8(6):29-30. 被引量:1
  • 2中华人民共和国卫生部心血管病防治研究中心.中国高血压防治指南(2005年修订版).北京:人民卫生出版社,2006:8.
  • 3中国高血压防治指南修订委员会.中国高血压防治指南(2010年修订版).北京:人民卫生出版社,2010:17-18.
  • 4Wu Xigui,Duan Xiufang,Huang Wen Yong,et aL China's elderly iso- lated systolic high Blood pressure prevalence and influencing factors of Chinese Journal of Cardiology [J]. 2003,31 (6) :456.
  • 5Khan NA, Hemmelgam B, Padwal R, et at. The 2007 Canadian Hyper- tension Education Program lecommendatiom for the management of hy- pertension: part 2-therapy [J]. Can J Cardiol, 2007,23 (7) :539 -550.
  • 6Hall FL Effective management Of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high eaiovatmular risk[J]. Int J Clin Pratt,2008,62 (5) :81-790.
  • 7Simons IA, Ortiz M, Calcino G. Persistence with antihypernsive med- ication: Australia-wide experience,2004-2006 [J]. Med J Aust, 2008, 188(4) :224-227.
  • 8鲁端.顽固性高血压的治疗[J].全科医学临床与教育,2008,6(1):3-7. 被引量:6
  • 9阳帆.氨氯地平、贝那普利、氢氯噻嗪三联治疗顽固性高血压的疗效观察[J].包头医学,2008,32(4):198-199. 被引量:2
  • 10王健,周惠,周卫民.苯磺酸氨氯地平对原发性高血压患者早期肾功能影响的临床观察[J].临床和实验医学杂志,2009,8(9):85-85. 被引量:3

共引文献12

同被引文献18

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部